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Abstract
Background: Brain inflammation is accompanied by brain injury. However, it is controversial whether inflammatory
responses are harmful or beneficial to neurons. Because many studies have been performed using cultured microglia and
neurons, it has not been possible to assess the influence of multiple cell types and diverse factors that dynamically and
continuously change in vivo. Furthermore, behavior of microglia and other inflammatory cells could have been overlooked
since most studies have focused on neuronal death. Therefore, it is essential to analyze the precise roles of microglia and
brain inflammation in the injured brain, and determine their contribution to neuronal damage in vivo from the onset of
injury.
Methods and Findings: Acute neuronal damage was induced by stereotaxic injection of ATP into the substantia nigra pars
compacta (SNpc) and the cortex of the rat brain. Inflammatory responses and their effects on neuronal damage were
investigated by immunohistochemistry, electron microscopy, quantitative RT-PCR, and stereological counting, etc. ATP
acutely caused death of microglia as well as neurons in a similar area within 3 h. We defined as the core region the area
where both TH
+ and Iba-1
+ cells acutely died, and as the penumbra the area surrounding the core where Iba-1
+ cells
showed activated morphology. In the penumbra region, morphologically activated microglia arranged around the injury
sites. Monocytes filled the damaged core after neurons and microglia died. Interestingly, neither activated microglia nor
monocytes expressed iNOS, a major neurotoxic inflammatory mediator. Monocytes rather expressed CD68, a marker of
phagocytic activity. Importantly, the total number of dopaminergic neurons in the SNpc at 3 h (,80% of that in the
contralateral side) did not decrease further at 7 d. Similarly, in the cortex, ATP-induced neuron-damage area detected at 3 h
did not increase for up to 7 d.
Conclusions: Different cellular components (microglia, astrocytes, monocytes, and neutrophils) and different factors
(proinflammatory and neurotrophic) could be produced in inflammatory processes depending on the nature of the injury.
The results in this study suggest that the inflammatory responses of microglia and monocytes in response to ATP-induced
acute injury could not be neurotoxic.
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Introduction
Brain inflammation is emerging as an important target of drug
development in the treatment of acute and degenerative brain
diseases. Several studies have shown that brain inflammation
accompanying injury is mainly mediated by resident microglia,
and inflammatory responses are harmful to surrounding neurons
due to the cytotoxicity of mediators, such as nitric oxide (NO) and
TNF-a [1–8]. However, other studies have challenged this general
concept. Firstly, brain inflammation may be a complex process
involving blood inflammatory cells as well as microglia. We and
others have reported that neutrophils and/or monocytes infiltrate
traumatic, ischemic, and LPS-injected brain and that neutrophils
rather than microglia express neurotoxic iNOS and TNF-a
[9–19]. In animal models of Alzheimer’s disease, monocytes
infiltrate brains [20,21]. Secondly, neuroprotective roles of
inflammatory responses are reported. Microglia/monocytes
phagocyte dying cells and debris, and produce neurotrophic
factors, such as transforming growth factor-b1 (TGF-b1), neu-
trophin-3 (NT-3), and brain-derived neurotrophic factor (BDNF)
[22–26]. Because most studies have been performed using cultured
microglia and neurons, it has not been possible to assess the
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and continuously change in vivo. Furthermore, most such studies
have focused on neuronal death; thus, the behavior of microglia
and other inflammatory cells could have been overlooked.
Therefore, it is essential to analyze the precise roles of microglia
and brain inflammation in the injured brain, and determine their
contribution to neuronal damage in vivo from the onset of injury.
ATP has been considered an endogenous factor that induces
neuronal damage and inflammatory responses. Under some
pathological conditions, such as ischemia and hypoxia, the
extracellular ATP level rises due to release from damaged cells
[27–30]. ATP directly induces neuronal death [31]. ATP also
activates microglia: microglia rapidly move their processes towards
ATP [32], and produce IL-1b, TNF-a, and ROS in response to
ATP [33–36]. Furthermore, blocking of ATP receptors reduces
brain injury [27–29,37]. Thus, ATP is a suitable insult to mimic in
vivo brain injury.
In this study, we injected ATP into the substantia nigra pars
compacta (SNpc, Parkinson’s disease- related brain area) and the
cortex, and investigated inflammatory processes and their effects
on neuronal damage. Interestingly, microglia died as early as
neurons within the core region, indicating that microglia are as
vulnerable to insult as neurons. Microglia in the penumbra region
surrounded the injury sites, and cells highly expressing CD45
+ (a
marker of monocytes) appeared at around 2 d. However, neuron-
damage area detected at 3 h did not increase further for up to 7 d
in both SNpc and cortex. Therefore, microglia/monocytes appear
to isolate injury sites and/or remove damaged cells rather than
causing delayed neuronal death at least in the ATP-injected brain.
Materials and Methods
Ethics Statement
All experiments were performed in accordance with the
approved animal protocols and guidelines established by the Ajou
University School of Medicine Ethics Review Committee for
animal experiments, and all animal work was approved by the
Ethical Committee for Animal Research of Ajou University
(Amc-28).
Stereotaxic surgery and drug injection
SD rats were anesthetized by injection of chloral hydrate
(0.4 mg/kg, i.p.), and positioned in stereotaxic apparatus (David
Kopf Instruments, Tujunga, CA). ATP (10–1000 nmol in 2 ml
sterile PBS; Sigma, St. Louis, MO) was unilaterally administered
into the right SNpc (AP, 25.3 mm; ML, 22.3 mm; DV,
27.6 mm from bregma) and cortex (AP, +0.7 mm; ML,
22.0 mm; DV, 22.0 mm from bregma), according to the atlas
of Paxinos and Watson [38]. All animals were injected using a
Hamilton syringe equipped with a 30-gauge blunt needle to
minimize mechanical damage attached to a syringe pump (KD
Scientific, New Hope, PA). ATP was infused at a rate of 0.4 ml/
min. After injection, the needle was held in place for an additional
5 min before removal. PBS-injected animals or contralateral sides
were used as control.
Tissue preparation
Rats were anesthetized and transcardially perfused with saline
solution containing 0.5% sodium nitrate and heparin (10 U/ml),
followed by 4% paraformaldehyde in 0.1 M phosphate buffer,
pH 7.2, for tissue fixation. Brains were obtained and post-fixed
overnight at 4uC in 4% paraformaldehyde. Fixed brains were
stored at 4uC in 30% sucrose solution until they sank. Six separate
series of 30 mm coronal brain sections (50 mm for stereological
counting) were obtained with a sliding microtome (Microm,
Walldorf, Germany). For RNA preparation, rats were anesthetized
and transcardially perfused with saline solution without prarfor-
maldehyde. Brains were obtained and sliced with Rat Brain Slicer
Matrix (1.0 mm slice intervals, RBM-4000C, ASI Instruments,
Warren, MI) and a razor blade. The slice including the needle
injection spot was selected, and tissue blocks (26262m m
3) just
below the needle tip were collected, and stored at 270uC until use.
Monocytes isolation and transplantation
Rat blood monocytes were isolated by density gradient
centrifugation [39] using endotoxin-free Ficoll-Paque PLUS (GE
Healthcare, Uppsala, Sweden). Briefly, blood was mixed with
2.5% dextran in PBS (blood: dextran solution, 1:4) for 1 h at RT.
The plasma layer was loaded onto Ficoll, and centrifuged at 4006
g for 30 min. The monocytes layer displaying a white band at the
interface was carefully collected and washed 3 times with PBS.
Then, monocytes were stained with 10 mM CFDA-SE for 10 min
at 37uC. Cells were washed 3 times with PBS, resuspended in PBS.
CFDA-labeled monocytes (1610
8 cells/300 ml) were transplanted
through the tail vein at 12 h after ATP injection into the SNpc.
Rats were sacrificed 2 d after ATP injection.
Immunohistochemistry
For 3, 39-diaminobenzidine (DAB) staining, serial sections were
rinsed three times with PBS, treated with 3% H2O2 for 5 min, and
rinsed with PBS containing 0.2% Triton X-100 (PBST). Non-
specific binding was blocked with 1% BSA in PBST. Sections were
incubated overnight at room temperature with primary antibodies
against tyrosine hydroxylase (TH; 1:2000 dilution; Pelfreeze
Biologicals, Rogers, AR), ionized calcium binding adaptor
molecule 1 (Iba-1; 1:1000; Wako Pure Chemical Industries,
Osaka, Japan), myeloperoxidase (MPO; 1:1000; Dako, Glostrup,
Denmark), CD45 (1:200; AbD Serotec, Oxford, UK), CD11b
(OX-42; 1:200; Serotec, Oxford, UK), Ki-67 (1:100; Abcam,
Cambridge, UK), interleukin-1b (IL-1b; 1:200; R&D systems,
MN), inducible nitric oxide synthase (iNOS; 1:200; Abcam,
Cambridge, UK), CD68 (1:200; AbD Serotec, oxford, UK) or
Neuronal Nuclei (NeuN; 1: 300; Chemicon, CA, USA). Following
rinsing in PBST, sections were incubated with biotinylated
secondary antibodies (Vector Laboratories, Burlingame, CA) for
1 h and the avidin/biotin system (Vector Laboratories, Burlin-
game, CA) for 1 h and visualized using DAB solution (0.05% DAB
and 0.003% hydrogen peroxide in 0.1 M PB). For double-labeling
with TH and Iba-1, sections were stained with TH antibody
following the above procedure, and visualized with DAB (brown
product). And then, same sections were washed in PBS, blocked
with 1% BSA, incubated with Iba-1 antibody, and visualized using
DAB/nickel sulfate solution (dark purple products) according to
the manufacturer’s guidance. Next, sections were mounted on
gelatin-coated slides, and examined under a bright field micro-
scope (Olympus Optical, BX51, Tokyo, Japan). Bright field images
were obtained using PictureFrame Application 2.3 software. For
immunofluorescence staining, sections were washed twice in PBS,
treated with 1% BSA, and incubated with combinations of
antibodies against Iba-1, iNOS, interleukin-1b, CD68, CD11b,
CD45, Ki67, TH and NeuN. Visualization was performed with
Alexa Fluor488- or Alexa Fluor555- conjugated secondary
antibodies (1:600 dilution; Invitrogen, Eugene, OR, USA). DAPI
(Vector Laboratories, Burlingame, CA) was used to detect nuclei.
Sections were analyzed under a confocal microscope (Carl Zeiss,
Germany) with 406 water and 636 oil immersion objectives at
20uC, and images were captured using Confocal software (LSM
Image Browser).
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At 3 h after ATP injection, brains were obtained and sliced
(1.0 mm slice) with Rat Brain Slicer Matrix and a razor. ATP-
injected SNpc tissue blocks (smaller than 16161m m
3) were
collected and post-fixed overnight at 4uC using Karnovsky’s
fixative solution (2% paraformaldehyde, 2% glutaraldehyde, 0.5%
calcium chloride in cacodylate buffer, pH 7.2), washed with
cacodylate buffer, dehydrated in a series of graded ethanol washes,
and embedded in Epon mixture. Semi-thin (1 mm thickness)
sections were cut and stained with toluidine blue for examination
under a light microscope to determine tissue orientation. Ultrathin
sections (70,80 nm) were obtained using a Reichert Jung
Ultracut S microtome (Leica, Vienna, Austria), mounted on grids,
stained with uranyl acetate and lead citrate, and analyzed under a
Zeiss EM 902 A electron microscope (Leo, Oberkohen, Germany).
Quantitative real-time PCR (Q-PCR)
Total RNA was isolated using an easy-BLUE RNA Extraction
Kit (iNtRON, Sungnam, Korea), and cDNA was prepared using
Reverse Transcription Master Premix (ELPisbio, Taejeon, Korea),
according to the manufacturers’ instructions. For Q-PCR,
approximately 50 ng cDNA was analyzed using a KAPA SYBR
FAST qPCR Kit (KAPA Biosystems, Boston, MA) and a Corbett
Rotor-Gene 6000 real-time rotary analyzer (Corbett Research,
Mortlake, NSW, Australia). Specific primers for IL-1b, TNF-a,
IL-6, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
used in Q-PCR are shown in Table 1. Q-PCR conditions were as
follows: 95uC for 30 s, followed by 40 cycles of 95uC for 3 s
(denaturation), 55uC for 20 s (annealing), and 72uC for 3 s
(elongation). For TNF-a, the annealing conditions were modified
to include a 63uC–59uC touch-down protocol, decreasing
temperature by 0.5uC per cycle for the first 8 cycles. That a
single product was amplified under the conditions used was
confirmed by performing a melting curve analysis for each primer
pair, using a melt ramp of 72uC–95uC and raising the temperature
by 1uC at each step (5 s/step). Amplified products were also
verified by electrophoresis on 1.5% agarose gels with GelRed
(Biotium, USA) staining. Results were normalized to GAPDH,
used as a reference.
Stereological analysis of dopaminergic neurons
Coronal brain sections (50 mm) were obtained and stained with
TH antibodies. The number of TH
+ neurons in the entire SNpc
was counted under a bright field microscope (Olympus Optical,
BX51, Tokyo, Japan) using Stereo Investigator software (MBF
Bioscience, Williston, VT). Counting frames (100 mm 6100 mm)
were randomly placed on the SNpc, and TH
+ neurons counted
under a 40x objective.
Statistical Analysis
Statistical data were expressed as means 6 SEM. The
significance of data was analyzed with one-way ANOVA using
the Statistical Package for Social Sciences (SPSS) 12.0.
Results
Time-dependent behavior of inflammatory cells in
response to ATP injection
To evaluate brain inflammatory cell behavior in response to
injury, we injected ATP into the substantia nigra pars compacta
(SNpc), the brain area closely related to Parkinson’s disease. ATP
was selected as the insult because it is released from damaged cells
and induces neuronal death [27–29,31,37], and inflammatory
responses in microglia and macrophages [33–36]. Within 3 h,
ATP (100 nmol in 2 ml PBS) locally induced loss of ionized
calcium binding adapter molecule-1–immunopositive (Iba-1
+)
microglia as well as tyrosine hydroxylase–immunopositive (TH
+)
dopaminergic neurons (Figure 1A, asterisks: injection sites). PBS
and 10 nmol ATP had little effect, while 1000 nmol ATP induced
a severe reduction in TH
+ neurons and Iba-1
+ microglia
(Figure 1A, and Figure S1). The damage area of Iba-1
+ cells was
similar to that of TH
+ cells (Figure 1A), which was further
confirmed with staining of serial sections with TH (Figure 1B left
panel), Iba-1 (Figure 1B middle panel), and a combination of TH/
Iba-1 (Figure 1B, right panel). Damage areas were marked with
dotted lines (Fig. 1B). Electron micrographs confirmed the death of
neurons and other glial cells, rather than a mere decrease in
immunoreactivity of TH and Iba-1: in intact rat brain, neuron (N),
astrocyte (A), and microglia (M) were shown whereas in ATP-
injected brain, cellular structures were disrupted (Figure 1C).
Based on these results, we employed 100 nmol ATP to induce
microglia/neuron damage, and defined the area where both TH
+
and Iba-1
+ cells died in response to ATP injection as the core
region.
Next, we investigated the time-dependent behavior of Iba-1
+
cells from 3 h to 83 d after ATP injection. In the contralateral
intact brain, Iba-1
+ cells were evenly distributed (Figure 2a) and
displayed highly ramified morphology (Figure 2b, higher magni-
fication image of the dotted line in Figure 2a). At 3 h, in the core
region (marked with asterisks), most Iba-1
+ cells disappeared
(Figure 2c, d), although the debris remained (black arrows in
Figure 2d). However, in the penumbra region, processes of Iba-1
+
cells became thick and short (arrowheads in Figure 2d), and cells
near the core appeared to be arranged so that the core was isolated
(white arrows in Figure 2c, d). At 1 d, some Iba-1
+ cells near the
core region became rod-shaped (white arrows in Figure 2f), and
Iba-1
+ cells beneath this area had thick, long process that headed
towards the core region (arrowheads in Figure 2f). At 2 d, the
number of Iba-1
+ cells increased (Figure 2g, h), and round Iba-1
+
cells appeared in the core and penumbra regions (white arrows in
Figure 2h). At 3 d, the densities of round Iba-1
+ cells increased
(Figure 2i, j), and at 7 d, the core was densely filled with round
Iba-1
+ cells (Figure 2k, l). At 14 d, the number of round Iba-1
+
cells was significantly reduced (Figure 2m, n), and most became
ramified (white arrows in Figure 2n). At 83 d, most Iba-1
+ cells
were ramified (Figure 2p); only those Iba-1
+ cells located at the
needle tip still displayed a round shape (Figure 2o, p, and inset in
Figure 2p). In the control SNpc injected with PBS (2 ml), Iba-1
+
cells observed at 3 h had not died but their processes had
retracted. At 1 d and 3 d, Iba-1
+ cells in the PBS-injected brain
Table 1. List of primer sequences for Q-PCR.
Gene Sequence (59-39)
IL-1b F- TGATGTTCCCATTAGACAGC
R- GAGGTGCTGATGTACCAGTT
TNF-a F- GTAGCCCACGTCGTAGCAAA
R- CCCTTCTCCAGCTGGGAGAC
IL-6 F- AAAATCTGCTCTGGTCTTCTGG
R- GGTTTGCCGAGTAGACCTCA
GAPDH F- TCCCTCAAGATTGTCAGCAA
R- AGATCCACAACGGATACATT
F, Forward primer; R, Reverse primer.
doi:10.1371/journal.pone.0013756.t001
Brain Inflammation
PLoS ONE | www.plosone.org 3 October 2010 | Volume 5 | Issue 10 | e13756once again became ramified, but had thicker processes than those
in the intact (uninjected) brain (Figure S2). However, the round
Iba-1
+ cells observed in ATP-injected brains were not detectable in
PBS-injected brains (Figure S2). These results indicate that Iba-1
+
cells are vulnerable to ATP-induced damage and dramatically
alter their morphology and number in response to damage.
Monocytes but not neutrophils infiltrate the ATP-injected
brain
Since the number of round Iba-1
+ cells was significantly
increased from 2 d after ATP injection, we investigated the
cellular sources. Initially, we examined the possibility of prolifer-
ation of Iba-1
+ microglia from the penumbra regions. Cells
expressing Ki-67 (a cell cycle protein used as a proliferation
marker) were detectable at 2 d after ATP injection, and
significantly increased at 3 d, but decreased at 7 d (Figure 3A).
Ki-67
+ cells were barely detectable in PBS-injected SNpc and
intact SNpc (Figure 3A). To ascertain whether microglia were Ki-
67
+, we performed double immunolabeling using CD11b and Ki-
67 antibodies. Since both Iba-1 and Ki-67 antibodies were
generated in the same species of animals (rabbits), CD11b
antibodies generated in mice were employed to detect microglia.
Interestingly, Ki-67 immunoreactivity (arrowheads in Figure 3B)
did not match that of CD11b (arrows in Figure 3B). These results
clearly indicate that microglia do not actively proliferate in the
ATP-injected brain.
Next, we examined the possible infiltration of blood monocytes,
in view of previous reports that monocytes express Iba-1 and
infiltrate the damaged brain [11,15,17,20,21]. We stained sections
obtained at 2–7 d after ATP injection with CD45 antibodies, since
expression levels of CD45 were low in microglia and high in blood
monocytes [40–42]. Interestingly, round CD45
+ cells were densely
located in the penumbra region at 2 d (Figure 4Aa, b) and 3 d
(Figure 4A), and filled the core by 7 d (Figure 4Ac). CD45
+ cells
were tightly bound to blood vessels (Figure 4Aa) and their location
at 2 d and 3 d was similar to that of round Iba-1
+ cells, as shown
in Figure 2. In the intact contralateral side, CD45
+ cells were not
Figure 1. Death of dopaminergic neurons and microglia in the SNpc induced by ATP. (A) ATP (100 nmol in 2 ml PBS) or PBS (2 ml) was
unilaterally injected into SNpc (*, injection sites), and brains were obtained after 3 h. Brain sections (30 mm thickness) of the midbrain including the
entire SN were prepared, every sixth serial section selected and stained with TH (upper panel) and Iba-1 (lower panel) antibodies, and visualized with
biotin-conjugated secondary antibodies and enzymatic detection with the avidin/biotin system unless indicated. At 100 nmol, mild neuronal and
microglial damage occurred, thus, 100 nmol ATP was employed for in vivo experiments in this study. Photographs of the most damaged sections
were obtained. The contralateral side (contra) and PBS-injected rat brain sections were used as control. (B) Serial sections obtained at 3 h were
labeled with TH (left panel), Iba-1 (middle panel), and TH/Iba-1 (right panel) antibodies. For visualization of the double-labeling, color reactions using
DAB (for TH) and DAB/nickel sulfate (for Iba-1) were applied. Dotted lines indicated damage areas. (C) Brain tissue obtained 3 h post ATP treatment
was subjected to electron microscopy, as described in ‘‘Materials and Methods’’. Nuclei of neuron (N, white arrow), astrocytes (A, white arrowhead),
and microglia (M, black arrow) were shown in intact rat brain whereas cellular structures were severely disrupted in ATP-injected brain. Data in this
study are representative of at least 5 animals. Scale bars, 200 mm (A); 100 mm (B); 5 mm (C).
doi:10.1371/journal.pone.0013756.g001
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+ cells in ATP-injected SNpc. Serial sections obtained 3 h ,83 d after ATP injection (*, injection
sites unless indicated) were processed for Iba-1 immunostaining, as described for Figure 1. Photographs of the most damaged sections were
obtained. The lower panel represents higher magnification of the indicated area in the upper panel. ATP rapidly altered the behavior of Iba-1
+ cells,
and its effects lasted at least for 83 d. Black arrows in (d) show debris remained. Arrowheads in (d) and (f) indicate thick and short process-bearing Iba-
1
+ cells. White arrows represent Iba-1
+ cells arranged around the injury site (c, d), rod-shaped cells (f), round cells (h, j, and l), and ramified cells (n, p).
Inset in (p) shows that some Iba-1
+ cells located at the needle tip still displayed a round shape. Data are representative of results obtained from at
least 5 animals, unless indicated. Scale bars, 200 mm (upper panel); 100 mm (lower panel); 20 mm (inset).
doi:10.1371/journal.pone.0013756.g002
Brain Inflammation
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+ cells
were scattered at low density (Figure 4A). We further confirmed
that round Iba-1
+ cells detected in the penumbra region 2 d after
ATP injection were co-labeled with CD45 antibody (arrows in
Figure 4B), whereas Iba-1
+ ramified cells were barely labeled
(arrowheads in Figure 4B). We also confirmed monocyte
infiltration in rats transplanted with CFDA (carboxyfluorescein
diacetate)-labeled monocytes into the tail vein. Iba-1
+/CFDA
+
round cells were detectable at 2 d after ATP injection when
CFDA -labeled monocytes were transplanted at 12 h after ATP
injection (Figure 4C). These results indicate that Iba-1
+/CD45
+
monocytes actively infiltrate the ATP-injected brain.
Figure 3. Ki-67
+ immunoreactivity is detectable in ATP-injected SNpc, but not colocalized in CD11b
+ cells. (A) Brain sections were
prepared at the indicated times after ATP or PBS injection and stained with Ki-67 antibody. Photographs of the most damaged sections were
obtained. The insets represent higher magnification of the area indicated in the upper panel. The number of Ki-67
+ cells increased at 2 and 3 d, but
decreased at 7 d. (B) Sections obtained at 3 d were double-labeled with Ki-67 and CD11b antibodies, and visualized with Alexa Fluor555-
(arrowheads)- and Alexa Fluor488 (arrows)- conjugated secondary antibodies, respectively. Nuclei were labeled with DAPI. The majority of Ki-67
immunoreactivity was not detectable in CD11b
+ cells. Scale bars, 200 mm (A); 50 mm (A, insets); and 20 mm (B).
doi:10.1371/journal.pone.0013756.g003
Figure 4. Infiltration of monocytes in ATP-injected SNpc. (A) Sections were obtained at the indicated times after ATP or PBS injection, and
stained with CD45 antibody. Insets show higher magnification of boxed areas. (B) Sections were obtained 2 d after ATP injection, and double-labeled
with Iba-1 and CD45 antibodies. Round Iba-1
+ cells were CD45
+ (arrows) whereas ramified Iba-1
+ cells were CD45
- (arrowheads). (C) Infiltration of
blood-borne monocytes in ATP-injected SNpc. CFDA-labeled monocytes were transplantated into the tail vein of rats 12 h after ATP injection as
described in ‘‘Materials and Methods (Monocytes isolation and transplantation)’’. Brain sections were obtained at 2 d after ATP injection, and stained
with Iba-1 antibody and visualized with Alexa Fluor555- conjugated secondary antibody. Scale bars, 200 mm (A, upper panel); 50 mm (A, lower panel);
50 mm (B); 20 mm (C).
doi:10.1371/journal.pone.0013756.g004
Brain Inflammation
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inflammation, and LPS-injected, ischemic and traumatic brains
[9-19,43]. Accordingly, we examined whether neutrophils infil-
trate ATP-injected SNpc. However, ATP injection did not
significantly induce neutrophil recruitment. Only a few myeloper-
oxidase-immunopositive (MPO
+) neutrophils were detectable in
100 nmol ATP-injected SNpc from 12 h to 3 d (arrows in
Figure 5A). Even at 1000 nmol ATP, not many neutrophils were
detectable (arrows in Figure 5B), in contrast to LPS-injected SNpc
(Figure 5C). Neurons on the contralateral side were faintly stained
with MPO antibodies (arrowheads in Figure 5A). Accordingly,
neutrophil infiltration appeared variable, depending on the
damage insult. These results collectively suggest that monocytes
but not neutrophils infiltrate from the blood and largely contribute
to the increase in Iba-1
+ cells in the ATP-injected brain.
Expression profiles of inflammatory mediators in
ATP-injected SNpc
Next, we investigated the mRNA expression of inflammatory
mediators in the ATP-injected brain. IL-1b, TNF-a, and IL-6
mRNA reached peak levels within 3 h, were maintained (IL-1b
and IL-6) or slightly decreased (TNF-a) at 12 h, and then
decreased to or approached basal levels thereafter (Figure 6A).
Interestingly, the expression levels of all of these cytokines were
also increased in the PBS-injected brain, particularly IL-1b and
TNF-a, which were higher than in ATP-injected brain at 3 d and
12 h, respectively (Figure 6A).
We further examined the expression of inflammatory mediators
using an immunohistochemical approach. Interestingly, inducible
nitric oxide (iNOS) immunoreactivity was not detectable in the
ATP-injected SNpc for up to 7 d (Figure 6B, insets: higher
magnification of boxed areas). The absence of iNOS immunore-
activity in the ATP-injected brain was not due to experimental
error since iNOS was readily detected in brain sections obtained
from positive control rats systemically injected with LPS (data not
shown). In contrast to iNOS, IL-1b was strongly detected at 3 h,
decreased at 12 h, and disappeared at 3 d (Figure 6B). IL-1b was
detected in the penumbra region of the ATP-injected SNpc where
microglia were morphologically activated, but not in the core
where microglia had died (Figure 6B). IL-1b was also detectable in
the PBS-injected SNpc, but here it was present in both the
penumbra and core regions (Figure 6B). We next examined
phagocytic activity by probing for CD68, a widely used marker of
phagocytic activity [44–46]. In the ATP-injected brain, CD68
immunoreactivity was not detectable for up to 12 h, but appeared
at 1 d, and significantly increased at 3–7 d (Figure 6B) in areas
that were densely populated with round Iba-1
+ cells and/or
CD45
+ cells (Figure 2 and Figure 4A). In contrast, CD68
expression was barely detectable in the PBS-injected brain
(Figure 6B). In double-labeling experiments, cellular types that
expressed IL-1b and CD68 were identified. As expected, IL-1b
Figure 5. MPO
+ neutrophils are barely detectable in ATP-injected SNpc. Brain sections were obtained at the indicated times after injection
of 100 nmol ATP (A), 1000 nmol ATP (B)o r5mg LPS (C) into the SNpc. Neutrophils were identified using MPO antibody (arrows). Photographs of the
most damaged sections were obtained. In contrast to LPS, neutrophils were barely recruited upon treatment with ATP (100 and 1000 nmol). Lower
panel is higher magnification of the upper panel. Scale bars, 200 mm (A, B, C upper panels); 50 mm (A, B, C lower panels); 10 mm (inset).
doi:10.1371/journal.pone.0013756.g005
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PLoS ONE | www.plosone.org 7 October 2010 | Volume 5 | Issue 10 | e13756Figure 6. Expression of inflammatory mediators in ATP-injected SNpc. (A) At the indicated times after ATP or PBS injection, tissue blocks
(26262m m
3) were obtained, and mRNA levels of IL-1b, TNF-a, and IL-6 were analyzed with real time PCR. *, p,0.05 vs. intact; **, p,0.01 vs. intact;
#, ,0.05 between PBS vs. ATP. (B, C) Sections obtained at the indicated times were stained with IL-1b, iNOS or CD68 antibodies, and visualized with
biotin-conjugated secondary antibodies (B) or double-labeled with combinations of IL-1b/Iba-1 or CD68/Iba-1 antibodies, and visualized with Alexa
Fluor555- and Alexa Fluor488- conjugated secondary antibodies (C). Insets in (B) represent higher magnification of the boxed areas. Scale bars,
200 mm (B); 20 mm (B, insets); 20 mm (C).
doi:10.1371/journal.pone.0013756.g006
Brain Inflammation
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+ cells that were considered
microglia and monocytes, respectively (Figure 6C).
Delayed neuronal death is barely detectable in the
penumbra region where microglia are activated and
monocytes infiltrate
Since ATP injection did not significantly induced expression
of proinflammatory mediators, such as iNOS, IL-1b,a n dT N F -
a, we examined whether delayed neuronal damage occurred in
ATP-injected brain. We compared the neuron-damaged areas
at 3 h and 7 d. Interestingly, TH
+ neuron-negative areas
detected at 3 h were not increased at 7 d (Figure 7Ab, c).
TH
+ cells in the penumbra region were intact at 7 d as well as
3 h (dotted line in Figure 7Ab, c). A number of TH
+ neuronal
cell bodies detected in the core at 3 h looked unhealthy (arrows
in Figure 7Ae), and disappeared at 7 d (Figure 7Af). We
analyzed morphology of the nuclei of TH
+ neurons using DAPI
staining. The intensities of TH in the ipsi-lateral side slightly
reduced compared to that in the contra-lateral side. On the
contrary, the intensities of DAPI of TH
+ cells in the ipsi-lateral
side slightly increased compared to that in the contra-lateral side
(arrows in Fig. 7B) while the intensities of non-TH
+ cells little
changed (arrowheads in Fig. 7B). We further performed the
electron microscopy to verify the state of these TH
+ neuronal
cells. Electron microscopy confirmed that neurons in core
region at 3 h were not healthy, since cytosolic (cyt) and mi-
tochondrial structures (M, and insets in Figure 7C) disintegrat-
ed, compared to those in intact neurons (Figure 7C), which
constitute a marker of dying cells [47–49]. Importantly, the
characteristics of neuronal nuclei (N), pale and homogeneously
dispersed karyoplasms [50], were lost (Figure 7C), which is in an
accordance of the increase in DAPI intensity in ATP-injected
brain shown in Figure 7B. Based on these data, we defined the
unhealthy cells in core region at 3 h as ‘pathological neurons’
(arrows in Figure 7Ae). In stereological counts, only the
pathological neurons detected at 3 h disappeared at 7d, and
the total numbers of healthy TH
+ neurons estimated at 3 h and
7 d were similar, specifically, 81.162.8% (n=5) and 8061.9%
(n=5) of that in the contralateral side at 3 h and 7 d, res-
pectively (Figure 7C). Thus, we concluded that TH
+ neurons in
the SN remained in the core at 3 h after ATP injection were
dead and/or dying (pathological) neurons.
Figure 7. Delayed neuronal death is barely detectable in ATP-injected SNpc. (A) Midbrain sections including the entire SNpc were prepared
at 3 h and 7 d after ATP injection, and stained with TH antibody. The contralateral side (contra) was used as the control. The lower panel represents
higher magnification of boxed regions in the upper panel. The ATP-induced damage area detected at 3 h did not increase at 7 d (dotted lines in the
upper panel), although TH
+ neurons that appeared rough and unhealthy (pathological neurons, arrows in the ‘e’) disappeared at 7 d (f). (B) Sections
obtained at 3 h were labeled with TH antibody, and the nuclei were visualized with DAPI. Nuclei of TH
+ neurons and uncharacterized cells were
indicated by arrows and arrowheads, respectively. (C) Electron microscopic analysis was performed in the boxed regions in intact and ATP-injected
brain represented in (Aa and b). Mitochondria (M, insets) and cytosol (cyt) were indicated. (D) Using stereology, the total numbers of TH
+ neurons
were estimated in the contralateral and ATP-injected ipsilateral SNpc at 3 h (n=5) and 7 d (n=5), as described in ‘‘Materials and Methods’’. The
number of TH
+ neurons in the ipsilateral side was normalized to that in the contralateral side (contra) in each animal. Pathological TH
+ neurons
detected at 3 h were counted separately. Scale bars, 200 mm (A, upper panel); 50 mm (A, lower panel); 10 mm (B); 1.7 mm (C); 0.8 mm (C, inset).
doi:10.1371/journal.pone.0013756.g007
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infiltration occurs in the penumbra region containing live TH
+
neurons. Serial sections were obtained from ATP-injected SNpc at
3 d, and stained with TH and Iba-1 antibodies. Lower panels
(Figure 8Ac, d) are higher magnification images of the indicated
areas in the upper panels (Figure 8Aa, b). At 3 d, TH
+-neuron
negative and positive areas were clearly detected (dotted lines in
Figure 8Ac). In TH
+ neuron-negative area, round Iba-1
+ cells
reappeared (arrows in Figure 8Ad) while in TH
+ neuron-positive
area, morphologically activated thick process-bearing Iba-1
+ cells
were detected (arrowheads in Figure 8Ad). The morphology of
resting microglia in the contralateral side was shown in the inset
(Figure 8Ad). Double immunostaining experiments disclosed intact
TH
+ neuronal cell bodies (arrows in Figure 8B) with co-existence
of activated CD11b
+ cells (Figure 8B), which indicate that
morphologically activated Iba-1
+ cells were not cytotoxic to the
surrounding neurons.
We further examined ATP-induced inflammatory responses
and neuronal damage in the cortex. The behavior of NeuN
+
neurons and Iba-1
+ cells was similar to that in the SNpc. In the
core region, Iba-1
+ cells died within 3 h after ATP injection (black
arrows in Figure 9A). Round Iba-1
+ cells were detected at 3 d in
the core region (white arrowheads in Figure 9A). In the penumbra
region, processes of Iba-1
+ cells became thick and short within 3 h
(white arrows in Figure 9A), and further decreased at 3 d
(Figure 9A). However, at 7 d, Iba-1
+ cells became ramified again
(Figure 9A). Although NeuN
+ cells were detected in the injection
core at 3 h after ATP injection, these cells were either swollen
(arrowheads in the lower panels in Figure 9B) or shrunken (arrows
in the lower panels in Figure 10A), compared to NeuN
+ cells in the
contralateral side (Figure 9B). We further analyzed morphological
changes of the nuclei using NeuN/DAPI staining. In the
contralateral side, nuclei of NeuN
+ cells were round and healthy
(thin arrows in Figure 9C). However, in the core of the ipsilateral
side, nuclei of NeuN
+ cells were either swollen (thick arrows in
Figure 9C) or shrunk (arrow heads in Figure 9C), a sign of necrosis
and apoptosis, respectively [51,52]. Therefore, these results suggest
that remaining cells detected in the core at 3 h already underwent
dying processes due to direct toxicity of ATP. Importantly, the
NeuN-negative area detected at 3 d and 7 d did not increase,
compared to the damaged area at 3 h (dotted lines in Figure 9B).
At 3 d, the NeuN
+ cells in the penumbra region were healthy
(Figure 9B), while in the core region, swollen NeuN
+ cell bodies
disappeared and some shrunken cell bodies were remained (white
Figure 8. TH
+ dopaminergic neurons are healthy in the area where Iba-1
+ cells are morphologically activated within ATP-injected
SNpc. Brain sections were prepared 3 d after ATP injection. (A) Serial sections were stained with TH (a, c) or Iba-1 (b, d) antibodies, and visualized
with biotin-conjugated secondary antibodies. Lower panels represent higher magnification of the boxed areas in the upper panels. In the area
specified with arrows, TH
+ neurons disappeared (c) and round Iba-1
+ cells were densely located (d). In the area indicated by white arrowheads, TH
+
neurons were healthy (c) and Iba-1
+ cells were morphologically activated (d). The inset in (d) presents the morphology of Iba-1
+ cells in contralateral
SNpc. (B) Sections were double-labeled with TH and CD11b antibodies. Photographs were obtained at the area indicated with arrowheads in the
ipsilateral side in (A) and contralateral side (contra). TH
+ neuronal cell bodies are indicated with arrows. Scale bars, 200 mm (A, upper panel); 50 mm (A,
lower panel), 20 mm (A, inset), 50 mm (B).
doi:10.1371/journal.pone.0013756.g008
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+ cells in the cortex. ATP was injected into the cortex, and serial sections prepared
at the indicated times, and stained with Iba-1 (A) and NeuN (B) antibodies. The contralateral side (contra) was used as a control. (A) Within 3 h, Iba-1
+
cells underwent death in the core (black arrows) and activated in the penumbra region (white arrows). At 3 d, round Iba-1
+ cells were detectable in
the core (arrowheads), and Iba-1
+ cells filled the core at 7 d. (B) Neuron damaged areas were marked with dotted lines. At 3 h and 3 d, swollen (white
arrowheads) and shrunken (white arrows) neuronal cell bodies were detectable in the core. At 3 d and 7 d, healthy neurons were observed in the
penumbra region (outside of dotted lines). (C) Sections obtained at 3 h were labeled with NeuN antibody, and the nuclei were detected with DAPI.
The nuclei of NeuN
+ cells in the contralateral side were round and the boundary was clear (thin arrows). However, the nuclei of NeuN
+ cells in the
contralateral side were either swollen (thick arrows) or shrunk (arrowheads). Scale bars, 200 mm (A and B, upper panel); 100 mm (A and B, lower panel);
20 mm (C).
doi:10.1371/journal.pone.0013756.g009
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+ cells in the penumbra region
were still healthy, while in the core region, most NeuN
+ shrunken
cells disappeared (Figure 9B). These results indicate that ATP
induces brain injury and behavioral changes of microglia and
monocytes but that activated microglia and infiltrated monocytes
do not generate delayed neuronal damage in either SNpc or the
cortex.
Discussion
In this study, we examined the behavior of neurons, microglia
and other inflammatory cells in the ATP-injected brain as a model
system that mimics the brain injury. The major findings are as
follows: (1) microglia as well as neurons underwent death in the
damaged core; (2) monocytes as well as microglia contributed to
brain inflammation; and (3) inflammatory responses of microglia
and/or monocytes were not cytotoxic since there was no sign of
delayed neuronal death in the penumbra region.
In ATP-injected SNpc, microglia acutely died as early as
neurons, and round Iba-1
+ cells filled the microglia-dead area at
3–7 d (Figure 1, 2). Although the number of Ki67
+ cells increased
in 2 d and 3 d after ATP injection (Figure 3A), Ki67 immuno-
reactivity was not detected in CD11b
+ cell (Figure 3B), which
indicated that resident microglia did not actively proliferate in
ATP-injected brain. In accordance with a recent report that
astrocytes and oligodendrocytes actively proliferate in injured
brain [53], we also detected Ki67 immunoreactivity in GFAP
+
astrocytes in ATP-injected brain (data not shown). The round Iba-
1
+ cells filled the microglia-dead area were identified as infiltrated
monocytes in several ways. Iba-1
+ round cells detected at 3 d
expressed high levels of CD45 (Figure 4). CD45 was used as a
marker of monocytes, in view of the earlier finding that resident
microglia display low CD45 expression [40–42]. In addition,
CFDA-labeled monocytes transplanted into the tail vein were
detected in ATP-injected brain (Figure 4). We also could exclude
the possibility that ATP could enhance CD45 expression level in
microglia since CD45 expression was significantly stronger in
monocytes and microglia did not enhance CD45 expression even
in the presence of ATP (Figure S3).
The next arising issue was to understand the roles of resident
microglia activated in the penumbra region and infiltrated
monocytes in the core region. Inflammatory mediators from
microglia, such as nitric oxide and prostaglandins produced by
iNOS and COX-2, respectively, are cytotoxic in various animal
models [3,5,6,7]. Therefore, brain inflammation is suggested as a
cause of delayed neuronal injury that follows primary injury.
However, this general concept is not always true. In animal models
of Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and
multiple sclerosis, microglia possibly function in the maintenance,
repair or regeneration of the microenvironment [21,54,55]. As
observed in this study, the injury site and/or loss of neurons in
ATP-injected SNpc and cortex did not increase between 3 h and
7 d (Figure 7 and 9). In view of these inconsistent findings, it is
important to consider the factors that determine the presence or
absence of delayed injury. Firstly, differences in the extent of
neutrophil infiltration may influence the incidence of delayed
injury since neutrophils release neurotoxic factors, such as reactive
oxygen species, proteolytic enzymes, iNOS, and other proin-
flammatory mediators [9–19]. Previously, we have reported that
LPS slowly (at around 12–24 h) induced dopaminergic neuronal
death in the SN, but did not induce neuronal death in the cortex
[18]. LPS induced tremendous neutrophil infiltration in the SN
but much less in the cortex, and blocking of neutrophil infiltration
reduced neuronal death in the SN [18]. In ischemic, traumatic,
quinolic acid- and LPS-injected brains, neutrophils infiltrate and
induce delayed neuronal damage [13,14,17,18]. Furthermore,
neutrophil depletion reduces brain injury in these conditions
[12,13,18,56]. Compared to LPS, ATP is a weak inflammatory
stimulator (Figure S4), and barely recruited neutrophils (Figure 5).
Thus, the absence of neutrophil infiltration may not induce
delayed neuronal death in ATP-injected brain. Secondly, the
extent of damage could determine the absence or presence of
delayed neuronal death. When the amount of ATP increased 10
folds, from 50 mM to 500 mM, absolute neuron-damage areas
increased (Figure S5). However, neuron-damage area detected at
7 d rather slightly reduced compared to that at 3 h (Figure S5).
Based on these results, we concluded that the extent of damage
may not determine the absence or presence of delayed neuronal
death. Another factor that determines the presence or absence of
delayed neuronal damage could be the balance between
neurotoxic and neuroprotective factors produced by inflammatory
cells. ATP injection barely induced cytotoxic iNOS expression
(Figure 6), possibly because ATP is a weak inflammatory stimulus
for induction of iNOS expression (Figure S4). Furthermore,
astrocytes have been reported to suppress expression of iNOS
[57,58]. Although ATP induced mRNA and/or protein expres-
sion of IL-1b, TNF-a, and IL-6 (Figure 6), PBS, which did not
induce neuronal death, also induced these cytokines, and to a
greater degree than ATP. These findings suggest that IL-1b, TNF-
a, and IL-6 induction mechanisms are sensitive enough that the
expression of these cytokines can be stimulated by mechanical
damage (Figure 6A, B). Furthermore, these cytokines are rather
neuroprotective than neurotoxic since neurons in the penumbra
region where these cytokines were expressed were healthy
(Figure 6, 7, 8) and PBS did not induce neuronal damage (Figure
S1). These findings are in accordance with previous reports
showing that TNF-a and IL-6 released from ATP-treated
microglia could be neuroprotective [35,59,60]. In particular,
ATP-stimulated microglia have been reported to protect neurons
from glutamate-induced excitotoxicity [60], consistent with the
idea that growth factors produced by activated microglia could
exert beneficial effects on neurons in injury states.
Monocytes may act in repair by scavenging injured cells and cell
debris with strong phagocytic activity, as in systemic inflammation
where monocytes contribute to resolution and repair by removing
apoptotic cells and facilitating angiogenesis [61,62]. In the ATP-
injected brain, monocytes expressed CD68, a marker of
phagocytic activity [44–46]. (Figure 6). Accordingly, pathologically
shrunken neurons disappeared at around 3–7 d when monocytes
infiltrated in the SNpc (Figure 4, and 7). The remaining
monocytes may differentiate into microglia or undergo cell death
after scavenging and/or repairing damaged brain, since the
number of round cells abruptly decreased between 7–14 d and
ramified cells were detected around the injection sites (Figure 2).
Accordingly, at 83 d, the morphology of Iba-1
+ cells in the most
damaged area was similar to that in intact brain (Figure 2).
Although brain inflammation accompanies brain injury,
different cellular components (microglia, astrocytes, monocytes,
and neutrophils) and different factors (proinflammatory and
neurotrophic) could participate in inflammatory processes de-
pending on the nature of the insult or injury states. On the basis of
the results presented here and in previously reported studies
[17,18], we suggest that the inflammatory responses of monocytes
and microglia are not neurotoxic. These findings highlight the
importance of distinguishing between inflammatory factors that
are harmful and beneficial to neurons in diverse brain diseases,
and developing methods to selectively regulate harmful and
beneficial factors.
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Figure S1 Dose-dependent death of dopaminergic neurons and
microglia in the SNpc induced by ATP. ATP (10 or 1000 nmol
in 2 ml PBS) or PBS (2 ml) was unilaterally injected into SNpc
(*, injection sites), and brains were obtained 3 h (A) or indicated
times (B) after the injection. Brain sections (30 mm thickness) of the
midbrain including the entire SN were prepared, every sixth serial
section selected and stained with TH and/or Iba-1 antibodies, and
visualized with biotin-conjugated secondary antibodies. Photo-
graphs of the most damaged sections were obtained. The
contralateral side (contra) was used as a control (B). Scale bars,
200 mm.
Found at: doi:10.1371/journal.pone.0013756.s001 (1.18 MB TIF)
Figure S2 Behavior of Iba-1
+ cells in PBS-injected SNpc. Brain
sections (30 mm) were obtained at the indicated times after PBS
(2 ml) injection, and stained with Iba-1 antibody. Photographs of
the most damaged sections were obtained unless indicated. The
lower panel represents higher magnification of the area indicated
in the upper panel. *, Injection sites. Scale bars, 200 mm (upper
panel); 50 mm (lower panel).
Found at: doi:10.1371/journal.pone.0013756.s002 (2.07 MB TIF)
Figure S3 ATP does not change CD45 expression levels in
microglia and monocytes. Primary microglia were cultured from
the cerebral cortices of 1 to 3 day-old Sprague Dawley rats. Rat
blood monocytes were isolated by density gradient centrifugation,
as described in ‘‘Materials and Methods (Monocytes isolation and
transplantation)’’. CFDA (green)-labeled microglia and blood
monocytes were co-cultured and treated with 100 mM ATP for
12 h or left untreated, and stained with CD45 antibody. Cells
were CFDA-labeled microglia (arrowheads) displayed weak CD45
expression, even in the presence of ATP, while monocytes strongly
expressed CD45 (arrows). Scale bars, 20 mm
Found at: doi:10.1371/journal.pone.0013756.s003 (0.82 MB TIF)
Figure S4 ATP induces IL-1b, but not iNOS in primary
cultured microglia. Primary cultured microglia were treated with
100 mM ATP (in C, 100 mM or 1 mM) or 10 ng/ml LPS. At the
indicated times (A, B) or 24 h (C) after the treatment, IL-1b, TNF-
a, and iNOS mRNA (A) and protein (B) expression were
determined with RT-PCR and Western blot, respectively. (C)
The amount of nitrite formed from nitric oxide was measured by
mixing the microglia culture medium (50 ml) with an equal volume
of Griess reagent (0.1% naphthylethylene diamine, 1% sulfanil-
amide and 2.5% H3PO4). The optical density was measured at
540 nm. Values are presented as means 6 SEM of three samples.
#,p ,0.05 vs. values from untreated or ATP-treated microglia.
Found at: doi:10.1371/journal.pone.0013756.s004 (0.31 MB TIF)
Figure S5 No correlation between extent of brain damage and
delayed neuronal death. (A) Brain sections were prepared at 3 h
and 7 d after ATP (50 mM or 500 mM) injection into the cortex,
and stained with NeuN antibody. The contralateral side (contra)
was used as the control. Absolute damage areas increased with the
increase in amount of ATP (from 50 mM to 500 mM). However,
NeuN-negative areas did not increase between 3 h and 7 d. (B)
Every sixth cortical sections (bregma AP, +2.52 ,20.60 mm)
were stained with Cresyl Violet for Nissl staining. We used Nissl
staining instead of NeuN antibody staining since 500 mM ATP
induced severe damage in large area, thus damaged tissues were
sometimes lost during the NeuN antibody staining processes. Nissl-
negative areas were measured at 3 h and 7 d after ATP injection
using Axiovision image analysis software (version 4.7.2; Zeiss).
Neuron-damage areas induced by 500 mM ATP were rather
slightly reduced at 7 d compared to that at 3 h. (*, P,0.01). Scale
bar, 200 mm.
Found at: doi:10.1371/journal.pone.0013756.s005 (0.50 MB TIF)
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